Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study.

Item Type: | Letter |
---|
Title: | Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study. |
---|
Creators Name: | Launspach, M. and Temel, D. and Ohlendorf, E. and Zirngibl, F. and Materne, B. and Oevermann, L. and Deubzer, H.E. and Henssen, A.G. and Künkele, A. and Hundsdörfer, P. and von Bernuth, H. and Pruß, A. and Eggert, A. and von Stackelberg, A. and Lang, P. and Schulte, J.H. |
---|
Keywords: | Autologous Transplantation, Cohort Studies, Hematopoietic Stem Cell Transplantation, Retrospective Studies, Risk Factors, Rituximab |
---|
Source: | Haematologica |
---|
ISSN: | 0390-6078 |
---|
Publisher: | Ferrata Storti Foundation |
---|
Volume: | 108 |
---|
Number: | 1 |
---|
Page Range: | 267-272 |
---|
Date: | January 2023 |
---|
Official Publication: | https://doi.org/10.3324/haematol.2022.281134 |
---|
PubMed: | View item in PubMed |
---|
Repository Staff Only: item control page
Downloads per month over past year
|